Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCardiol Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2024 | 2 | -$0.10 | -$0.07 | -$0.09 |
| Q1 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
Cardiol Therapeutics Inc. Earnings Date And Information
Cardiol Therapeutics Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.13 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cardiol Therapeutics Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -3.61. Cardiol Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Cardiol Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | $0.00 | $0 | $0 | ||
| 06/28/2024 | Q2 2024 | -$0.10 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.14 | $0 | |||
| 04/01/2024 | Q4 2023 | -$0.10 | -$0.12 | -0.02 | $0 | |
| 11/14/2023 | Q3 2023 | -$0.12 | -$0.09 | 0.03 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.12 | -$0.12 | 0 | $0 | |
| 08/10/2023 | Q1 2023 | -$0.12 | -$0.11 | 0.01 | $0 | |
| 03/28/2023 | Q4 2022 | -$0.12 | $0 | |||
| 09/30/2022 | Q3 2022 | -$0.13 | $0 | |||
| 05/16/2022 | Q2 2022 | -$0.14 | -$0.10 | 0.04 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.14 | -$0.14 | -0 | $0 | |
| 12/31/2021 | Q4 2021 | -$0.11 | $0 | |||
| 09/30/2021 | Q3 2021 | -$0.23 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.16 | $78,760 | |||
| 03/31/2021 | Q1 2021 | -$0.26 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.29 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.13 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.13 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.11 | $0 | |||
| 12/31/2019 | Q4 2019 | -$0.12 | $0 |
Cardiol Therapeutics Inc. Earnings: FAQ's
When is Cardiol Therapeutics Inc.'s earnings date?
Cardiol Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
How can I listen to Cardiol Therapeutics Inc.'s earnings conference
call?
The conference call for Cardiol Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read Cardiol Therapeutics Inc.'s conference call transcript?
The conference call transcript for Cardiol Therapeutics Inc.'s latest earnings report can be read online.
How much profit does Cardiol Therapeutics Inc. generate each year?
Cardiol Therapeutics Inc. (:CRDL) has a recorded net income of $0. Cardiol Therapeutics Inc. has generated $-0.44 earnings per share over the last four quarters.
What is Cardiol Therapeutics Inc.'s price-to-earnings ratio?
Cardiol Therapeutics Inc. (:CRDL) has a price-to-earnings ratio of -3.61 and price/earnings-to-growth ratio is 0.18.